| dbo:abstract
|
- GenScript Biotech Corporation (Stock Code: 1548.HK) is a global biotechnology group, founded in New Jersey, United States in 2002, by Dr. Fangliang (Frank) Zhang, and listed on the Hong Kong Stock Exchange in 2015. Currently, the rotating CEO of GenScript is Dr. Zhenyu Liu., GenScript operates in over 100 countries and regions worldwide, with legal entities located in the US, China, Hong Kong, Japan, Singapore, the Netherlands, and Ireland. GenScript provides products and services to over 100,000 customers., Built upon leading gene synthesis technology, GenScript consists of four major groups:
* Life science group contract research organization (CRO) and products platforms, which provides customized services and catalog products
* Biologics contract development and manufacturing organization (CDMO) group
* Global cell therapy group
* Industrial synthesis product platform , As of June 30, 2020, GenScript had more than 3,900 employees globally, over 36% of whom hold master's and/or Ph.D. degrees. In addition, GenScript owns a number of intellectual property rights and trade secrets, including over 140 patents and over 450 pending patent applications. GenScript is driven by the corporate mission of “making people and nature healthier through biotechnology”. As of June 30, 2020, GenScript's products or services have been cited by 51,000 peer-reviewed journal articles worldwide. (en)
- 金斯瑞生物科技股份有限公司（英語：GenScript Biotech Corporation，港交所：1548），簡稱金斯瑞生物科技股份、金斯瑞生物科技，于2002年，由主席及行政總裁章方良、王魯泉和王燁，在美國新澤西州成立GS Corp，業務在全球經營生命科學研究與應用服務及產品銷售。 2017年12月27日，該公司收購美國CustomArray, Inc.，業務在全球經營學術及工業組織的供應。 (zh)
|
| rdfs:comment
|
- 金斯瑞生物科技股份有限公司（英語：GenScript Biotech Corporation，港交所：1548），簡稱金斯瑞生物科技股份、金斯瑞生物科技，于2002年，由主席及行政總裁章方良、王魯泉和王燁，在美國新澤西州成立GS Corp，業務在全球經營生命科學研究與應用服務及產品銷售。 2017年12月27日，該公司收購美國CustomArray, Inc.，業務在全球經營學術及工業組織的供應。 (zh)
- GenScript Biotech Corporation (Stock Code: 1548.HK) is a global biotechnology group, founded in New Jersey, United States in 2002, by Dr. Fangliang (Frank) Zhang, and listed on the Hong Kong Stock Exchange in 2015. Currently, the rotating CEO of GenScript is Dr. Zhenyu Liu., GenScript operates in over 100 countries and regions worldwide, with legal entities located in the US, China, Hong Kong, Japan, Singapore, the Netherlands, and Ireland. GenScript provides products and services to over 100,000 customers., (en)
|
